# Excella GmbH & Co. KG – FDA Inspection, Oct 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/excella-gmbh-co-kg/b8742aed-0db6-44e0-af06-1b4a0b1a5b62
Source feed: FDA_Inspections

> FDA inspection 1205496 of Excella GmbH & Co. KG, October 19, 2022. Classification: Voluntary Action Indicated (VAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205496
- Company Name: Excella GmbH & Co. KG
- Inspection Date: 2022-10-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1098271 - 2019-07-12](https://www.keypedia.com/records/fda_inspections/excella-gmbh-co-kg/4ac3f0b8-7ffe-4ca8-847d-71a06c7ee0ce)
- [FDA Inspection 1064238 - 2018-08-10](https://www.keypedia.com/records/fda_inspections/excella-gmbh-co-kg/20fb405a-3bbe-4ad3-9b2e-30067a3b80ee)
- FDA Inspection 1012240 - 2017-03-17
- FDA Inspection 933855 - 2015-05-29
- [FDA Inspection 831974 - 2013-05-17](https://www.keypedia.com/records/fda_inspections/excella-gmbh-co-kg/d6a54ce5-0fe9-4001-ba32-977c14744432)

Company: https://www.keypedia.com/companies/excella-gmbh-co-kg/82bb94ef-8b2e-4e51-8c40-b71a184257f1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c